Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

5,084 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
TWEAK mediates anti-tumor effect of tumor-infiltrating macrophage.
Kaduka Y, Takeda K, Nakayama M, Kinoshita K, Yagita H, Okumura K. Kaduka Y, et al. Among authors: takeda k. Biochem Biophys Res Commun. 2005 Jun 3;331(2):384-90. doi: 10.1016/j.bbrc.2005.03.176. Biochem Biophys Res Commun. 2005. PMID: 15850771
CAM and NK Cells.
Takeda K, Okumura K. Takeda K, et al. Evid Based Complement Alternat Med. 2004 Jun 1;1(1):17-27. doi: 10.1093/ecam/neh014. Evid Based Complement Alternat Med. 2004. PMID: 15257322 Free PMC article.
NK cells require IL-28R for optimal in vivo activity.
Souza-Fonseca-Guimaraes F, Young A, Mittal D, Martinet L, Bruedigam C, Takeda K, Andoniou CE, Degli-Esposti MA, Hill GR, Smyth MJ. Souza-Fonseca-Guimaraes F, et al. Among authors: takeda k. Proc Natl Acad Sci U S A. 2015 May 5;112(18):E2376-84. doi: 10.1073/pnas.1424241112. Epub 2015 Apr 21. Proc Natl Acad Sci U S A. 2015. PMID: 25901316 Free PMC article.
Interleukin 21 enhances antibody-mediated tumor rejection.
Smyth MJ, Teng MW, Sharkey J, Westwood JA, Haynes NM, Yagita H, Takeda K, Sivakumar PV, Kershaw MH. Smyth MJ, et al. Among authors: takeda k. Cancer Res. 2008 Apr 15;68(8):3019-25. doi: 10.1158/0008-5472.CAN-07-6019. Cancer Res. 2008. PMID: 18413772
5,084 results